re HDSN($7.46): Q3 analysts' estimate is just $.26 vs $.34, and Q4 estimate is just a penny vs $.13. Full-year 2023 estimate is $1.01 vs $1.75. Against that estimates backdrop the stock appears just slightly undervalued IMO. Plus the stock is still up 70% year-to-date...plenty of profits to be harvested...
We make a living by what we get, we make a life by what we give. --Winston Churchill
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.